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dissection was done successfully after then. Most patients with cancer of
unknown primary origin have a very poor prognosis because it is difﬁcult
to select appropriate treatment. Tumor marker provide not only as a tool
for monitoring but also a guide for chemotherapy regiment. Tumor marker
orientated chemotherapy makes operation more feasible and achieves
better diagnosis and treatment, as in the case describe here.
NDP009:
FUNCTIONAL ADRENAL ONCOCYTOMA (INCIDENTALOMA): A CASE
REPORT
Tsu-Feng Lin MD, Ding-Po Lin MD, Marcelo Chen MD, Jong-Ming Hsu MD.
Purpose: Oncocytic neoplasms are most commonly found in the kidney,
thyroid and salivary gland. Adrenal oncocytomas are very rare. There is
female predominance with a mean age of 46 years. These tumors are more
common on the left side (1:2). Most of these tumors are nonfunctional and
hence incidentally detected. Here, we report a case of functional adrenal
oncocytoma.
Case report: A 54-year-old female had past history of Type 2 Diabetes
mellitus and Hypertension undermedication control for ten years. She
felt gerneral weakness and abdominal discomforts for half year. There
were no palpitations, headache, weakness or fatigue, and the physical
examination was unremarkable. So she came to our Gastroenterology
outpatient department for further survey. Abdominal echo showed a
mixed hypoechoic lesion about 5cm at S6-7. The tumor has well margin,
echoic ring at the periphery without vascular invasion. Abdominal
computed tomography scan was performed after then and it showed a
right adrenal mass (6.3x4.8cm in size) with punctate calciﬁcation and
heterogeneous enhancement. 48 hours low dose dexamethasone sup-
pression test was arranged, and it showed positive. (base line: Cortisol/
ACTH: 20.16mg/dL /6.53pg/mL, post dexa: 18.88mg/dL /1.17 pg/mL). Other
Hemogram and serum biochemistry were within normal limits, except
polycythemia (hemoglobin: 17.7g/dl) that was same as before. The
tentative diagnosis is right adrenal incidentaloma with Cushing syn-
drome. She underwent laparoscopic adrenalectomy. The pathologic
report showed a well-encapsulated oncocytoma composed of nesting
and trabeculae polygonal cells with abundant granular, eosinophilic
cytoplasm. After sugery, she received regular OPD follow up in our hos-
pital without any complication.
Conclusion: Adrenal oncocytic neoplasm is usually a large, benign,
nonfunctional adrenal tumor and is found incidentally. Only 17% functional
adrenal mass (Cushing, pheochromocytoma, virilizing syndrome). The
mainstay of therapy is adrenalectomy, recently performed by laparoscopy.
The prognosis is good for benign tumors.
NDP010:
SYNCHRONOUS IPSILATERAL RENAL CELL CARCINOMA AND URO
THELIAL CARCINOMA OF KIDNEY OR URETER: CASES REPORT AND
LITERATURE REVIEW
Yu-Cheng Chang 1,2, Chia-Cheng Yu 1,2, Tony T. Wu 1,2. 1Division of Urology,
Kaohsiung Municipal Min-Sheng Hospital, Taiwan; 2Division of Urology,
Department of Surgery, Kaohsiung Veterans General Hospital, Taiwan
Purpose: We report 2 cases (a 63-year-old female and a 60-year-old fe-
male) were diagnosed of i Simultaneously ipsilateral urothelial carcinoma
(UC) of upper urinary tract and renal Cell carcinoma (RCC) had the
symptoms of painless gross hematuria and conﬁrmed by pathological
document.
Materials and Methods: In case 1 : The abdominal computed tomography
(CT) scan was described as left upper third ureter tumor with extension to
renal pelvis, measured about 4 cm in size, with post-contrast enhance-
ment, urothelial cancer was considered. In case 2 : The abdominal
computed tomography (CT) scan found a suspicious focal enhanced area is
noted in right kidney, 1.5 cm, RCC cannot be excluded, the ﬁndings should
be differentiated with inﬁltrated TCC in calyx.
Results: In case 1 : She received the operation of anterior exenteration and
the pathology showed urothelial carcinoma of left U/3 Ureter and clear cell
type renal cell carcinoma. In case 2 : She received rightnephroureterectomy with bladder cuff excision for urothelial carcinoma of
renal pelvis and unclassiﬁed renal cell carcinoma.
Conclusion: The most symptoms of the synchronous RCC and UC are ﬂank
pain and gross hematuria. Synchronous RCC and UC of the same kidney is a
rare condition and surgical intervention of radical nephroureterectomy
with bladder cuff excision may be a curative treatment for clinically
localized tumor.
NDP011:
RENAL CELL CARCINOMA WITH SYNCHRONOUS CONTRALATERAL
URETERIC METASTASIS e A CASE REPORT AND LITERATURE REVIEW
Kun-Lin Hsieh 1, Wei-Hong Lai 1, Steven Kuan-Hua Huan 2. 1Division of
Urology, Department of Surgery, Chi Mei Medical Center, Taiwan; 2Division
of Uro-Oncology, Department of Surgery, Chi Mei Medical Center, Taiwan
Purpose:When treating the renal cell carcinoma (RCC), preservation of renal
function is important as cancer control. Besides, metastasis of renal cell
carcinoma (RCC) to ureter is extremely rare. In our review, total 54 cases had
been reported about RCCwithuretericmetastasis and just only 11 patients of
them developed contralateral ureteric metastasis. We here presented RCC
with synchronous contralateral ureteric metastasis and our management to
this patient. We also reviewed the associated literature in this report.
Materials and Methods: A 61-year-old healthy man suffered from inter-
mittent painless hematuria for two months. He visited other hospital
ﬁrstly, where intravenous pyelography revealed obstructive lesion over
right ureter. He then went to our outpatient department for second
opinion. Impaired renal function with serum creatinine (Cr) showed
1.63 mg/dL and glomerular ﬁltration rate (GFR) calculated 34 ml/min.
Abdominal computed tomography (CT) revealed right upper-third ureter
tumor with moderate hydronephrosis. Besides, a tumor about 3cm at left
kidney was also detected, which favor RCC. Thus, the diagnosis ureter-
orenoscopy (URS) was performed, and pathology from endoscopic biopsy
to right ureter tumor presented with metastasis RCC.
Considering about preservation of renal function as well as principle of
RCC management, we performed the cytoreductive nephrectomy with
metastasectomy for him. Laparoscopic partial nephrectomy to left RCC and
segmental resection of right ureter with ureteroureterostomy was done.
The target therapy, Sunitinib, is also prescribed for the metastatic status of
RCC. He recovered well and no tumor progression found during six months
follow up till now. Image showed no dilatation of right pyelocalyceal
system, and postoperative renal function is preserved as Cr: 1.67 mg/dL at
3-month-later follow up.
Results: It is reported that approximately one third of patients with RCC
present with metastases. Several atypical presentations and rare meta-
static sites had been reviewed in the literature.1 RCC with ureteric
metastasis is very rare and just about 54 cases had been reported.2 Due to
only 4 cases had been reported of RCC presented as synchronous contra-
lateral ureteric metastasis, there is no consensus as to the most appro-
priate management.
Cytoreductive nephrectomy and surgical metastasectomy has been shown
to improve survival beneﬁt.3 It had been recommend as principle of
management metastasis RCC.4 Our patient has favorable outcome
including not only tumor prognosis but also renal function.
Besides, we also learned from this case that detailed evaluation to patient
with suspect ureter lesion is very important. Awareness of thesemetastatic
tumors could lead to early detection and improvement in management.5
Conclusion: In our review, this is the 5th case presented as RCC with
synchronous contralateral ureteric metastasis. Partial nephrectomy with
segmental resection of contralateral ureter seems effective as surgical
treatment. It had satisﬁed outcome in not only prognosis of cancer but also
renal function.
NDP012:
NEPHROGENIC ADENOMA OF URETER e CASE REPORT
Chin Wei Kuo, Meng-Yi Yan, Bai-Fu Wang. Divisions of Urology, Department
of Surgery, Changhua Christian Hospital, Changhua, Taiwan
Purpose: Nephrogenic adenoma is a rare benign lesion of urothelium. It is
usually occurred in urinary bladder. And in ureter, the recorded cases are
Abstracts / Urological Science 26 (2015) S50eS81 S53extremely rare. We report a case of nephrogenic adenoma arising from the
right lower ureter with clinical features suspicious of carcinoma
Materials andMethods: A 47 years old male, who complained about gross
hematuria with lower abdominal tenderness. KUB revealed Right M/3
ureter and renal echo revealed hydronephrosis. So URSL was arranged.
During operation, right lower third ureter papillary tumor with hyper-
vascular expression was noted. Urothelial carcinoma was impressed and
biopsy was done. However the pathological result revealed proliferation of
small, round to oval tubular structures lined by a regenerated urothelium.
The nuclei of these tubules did not show any mitotic activity. And neph-
rogenic adenoma is impressed. And he is free from disease for 6 months.
Results: Until now, nephrogenic adenoma is considered as a metaplastic
response of urothelium due to chronic irritation. The morphology of the
tumor is usually like urothelial carcinoma, with papillary expression and
hyper-vascular structure. However, under microscopic, therewas no nuclei
mitotic activity and immunohistochemically, the lesion was lake of CEA,
p53, cytokeratin 20. Nephrogenic adenoma is currently thought to have no
malignant potential. However, due to the risk of local recurrence, long term
follow up is suggested.
Conclusion: We present an extremely rare case that have nephrogenic
adenoma of ureter. And due to high risk of local recurrence with mass
effect related symptom, long term follow up may be needed.
NDP013:
STONE COMPONENT ANALYSIS OF 1000 PATIENTS IN YI-LAN COUNTY
Shyh-Chyi Chang 1,2, Hueih-Shing Hsu 1,2, Hsu-Hsiang Wang 1, Heng-Chang
Chuang 1, I-Hung Shao 1. 1Division of Urology, Department of Surgery, Lotung
Poh-Ai Hospital, Yi-Lan County, Taiwan; 2Department of Urology, School of
Medicine, National Yang-Ming University, Taipei, Taiwan
Purpose: The knowledge of urinary stone component plays an important
role in understanding pathophysiology, choice of treatment modality, and
prevention of recurrences of urolithiasis, Stone component revealed by
stone analysis study provides the information. We analyze the stone
analysis reports of 1000 patients in Yi-Lan county.
Materials and Methods: 1000 patients visited our hospital from Jan 2009
to Apr 2012 for urolithiasis treatment were included. Stone fragment
collected after extracoporal shock wave lithotripsy (ESWL), ureteroscopic
lithotripsy (URSL), percutaneous nephrolithotripsy (PCNL), vesicolitho-
tripsy, or other treatment procedure was sent for stone analysis study
(Fourier Transform Infrared Spectrophotometer, FTIR). Retrospective
analysis of patient gender, age, and the stone analysis data were evaluated.
Results: The average age of the 1000 patients is 53.1 year-old with 692
male patients. Pure single stone component (100%) of calcium oxalate,
calcium phosphate and uric acid were noted in 4.2%, 5.8%, and 7.0% pa-
tients with the male to female ratio as 83.33%, 48.28% and 84.29%. The
dominant stone component (>70%) of calcium oxalate, calcium phosphate
and uric acid were noted in 49.9%, 20.6%, and 7.6% patients. In 100 patients
with uric acid component, 70 patients belong to pure stone component
(100% uric acid). Protein calculi component was noted in 8 patients. 2 of
the patients have pure protein calculi. Cystine stone were noted in 1 pa-
tients with 100% cystine component.
Conclusion: In Yi-Lan county, most common stone component is calcium
oxalate. Near half patients have calcium oxalate component more than
70%. Compare to calcium oxalate and uric acid stone, calcium phosphate
stone were more common in female. Uric acid stone formed with high
purity. Further patient education in diet control and urinary tract infection
prevention seems to be important in prevent urolithiasis recurrence.
NDP014:
PARTIAL NEPHRECTOMY WITH VELA LASER IN RENAL CELL
CARCINOMA: CASE REPORT AND LITERATURE REVIEW
Ming-Hsiang Kuo, Kun-Hung Shen. Department of Surgery, Division of
Urology, Chi Mei Medical Center, Tainan, Taiwan
Purpose: Laser prostatectomy is increasingly being considered as a valid
clinical alternative to TURP which resulting in relatively low rates of
intraoperative and perioperative complications. Vela (1.9um thulium
laser) laser is also the optimum laser for interdisciplinary interventions inurology. We introduce a case or renal cell carcinoma receiving partial
nephrectomy with Vela laser.
Materials and Methods: This 48-year-old female patient had past history
of DM, HTN, Hyperlipidemia, Obesity (93 kg), left ureteral stone S/P URS-
SM, right ureteral stone s/p ESWL, right APN, Bilateral renal stones. She
suffered from gross hematuria for a month. The CTU showed: Right renal
nodule, exophytic nodular lesion about 2.2 cm. So she received right renal
biopsy on 2014/12/11. The pathology revealed: Clear cell renal cell carci-
noma(cT1aN0M0). Right retroperitoneal laparoscopic partial nephrectomy
with Vela laser was performed after discussing with the patient. Total
blood loss was 250 ml with warm ischemia time 30 mins. Post-operative
care was stable that she discharged on Post-operative Day 4. Pathology
was compatible with previous biopsy with free margin.
Conclusion: Laser its use in other endourology application or tumor
resection was relatively rare. We would like to introduce a case of our own
experience and the pros and cons compared with laparoscopic partial
nephrectomy in blood loss, surgical outcomes, length of hospitalization
and prognosis of disease control if available.
NDP015:
SURGICAL MANAGEMENT IN A PATIENT WITH RENAL CELL CARCINOMA
WITH INFERIOR VENA CAVA THROMBOSIS AND ANTRIALMETASTASIS e
CASE REPORT AND LITERATURE REVIEW
Ming-Chieh Kuo 1,2, Steven Kuan-Hua Huan 1, Nan-Chun Wu2. 1Division of
Urology, Department of Surgery, Division of Uro-Oncology, Taiwan; 2Division
of Cardiovascular Surgery, Chi Mei Medical Center, Tainan, Taiwan
Background: Patients with metastatic renal cell carcinoma (RCC) or who
develop metastases following prior treatment are generally managed with
systemic therapy, primarily using agents targeting the vascular endothelial
growth factor (VEGF) pathways. However, surgery continues to play an
important role in the management of these patients in some ways. A ne-
phrectomy can be a part of a combined approach to decrease the bulk of
tumor prior to systemic therapy, while a metastasectomy can be per-
formed in patients with one or a very limited number of metastases.
Case Report: We presented a 75 years-old gentleman who sufferedfrom
right renal tunorwith inferior vena cava thrombosis and right antrum
metastasis.The chief complaint was dyspnea and poor appetite for 6
months. For pending heart failure, surgical intervention including right
transperitonealredical nephrectomy andresection of inferior vena cava and
right antrial tumor was performed.
Conclusion: As metastasectomy of lung, bone, brain, and intra-abdominal
organs had been reported according to previous literature, clinical expe-
rience in metastasectomy of vascular system including major vessel and
heart was limited. We reviewed the management of these patients and
surgical outcome if surgical intervention was performed according to
previous literature.Urolithiasis
NDP016:
SINGLE CENTER, SINGLE OPERATOR COMPARATIVE STUDY
OF THE EFFICACY AND OUTCOMES OF ELECTROHYDRAULIC AND
ELECTROMAGNETIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPTORS
Chih-Chiao Lee MD, Ding-Po Lin MD.
Purpose: To compare the efﬁcacy and outcomes of two types of shock
wave machines, the electrohydraulic lithotriptor (E3000) and electro-
magnetic lithotriptor (EM1000), as treatment of upper urinary tract stones.
Materials and Methods: The efﬁcacy and outcomes of shock wave litho-
tripsy (SWL) using Medispec's E3000 electrohydraulic shock wave litho-
triptor (179 cases) and Medispec's EM1000 electromagnetic shock wave
lithotriptor (93 cases) in 272 patients with upper urinary tract stones
between January 2011 and June 2013 were reviewed. The same operators
performed all of the SWL treatments under the supervision of urologists in
a single center. The demographic features, treatment parameters (i.e.,
stone site and size), and complications for both lithotriptors were
analyzed. The patients were evaluated within 4 weeks after lithotripsy by
